Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Andrew L, Pecora"'
Autor:
Scott M. Berry, Brett E. Lewis, Virginia Gadalla, Michael Marafelias, Andrew McConnell, Andrew Ip, Andrew L. Pecora, Donald A. Berry, Ihor S. Sawczuk, Puneet Kaur, Zachary Sica, Urszula Bednarz, Michael Koropsak, Mary Mrkulic, Michelle Serna, Burcu Sat, Stuart L. Goldberg, Kristen Wright, Katerina Trpeski, Nicholas S. Berry, Rashmi Unawane, Andre Goy
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255228 (2021)
BASE-Bielefeld Academic Search Engine
PLoS ONE
BASE-Bielefeld Academic Search Engine
PLoS ONE
Objectives The development of a prognostic mortality risk model for hospitalized COVID-19 patients may facilitate patient treatment planning, comparisons of therapeutic strategies, and public health preparations. Methods We retrospectively reviewed t
Autor:
Eric Hansen, Samuel La Capra, Ihor S. Sawczuk, Greggory E. Mojares, Michael Marafelias, Arthur Calise, Brittany A Sinclaire, Bradley L. Pulver, Andrew L. Pecora, Joseph P. Underwood, Andrew Ip, Frank J. Cunningham, Jaeil Ahn, Marie G. Ponce, Robert L. Sweeney, Dominic Ruocco, David M Walker, Rajiv Prasad, Yizhao Zhou, Paul Mastrokyriakos, Stuart L. Goldberg, Kristy L. Ziontz, Michael P. Eagan, Urszula Bednarz, Andre Goy
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
BackgroundHydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d441f1d43e8919063ba30fa9b357ee15
https://doi.org/10.1101/2020.08.20.20178772
https://doi.org/10.1101/2020.08.20.20178772
Autor:
Andre Goy, Joseph P. Underwood, Ihor S. Sawczuk, Noa Biran, Andrew Ip, Eric Hansen, Brittany A Sinclaire, Arif Asif, Steven J. Sperber, Stuart L. Goldberg, Lisa Tank, Keith M. Rose, Donald A. Berry, Jerry Zuckerman, Andrew L. Pecora, Nicholas S. Berry, Carol L. Barsky, Sarah L. Timmapuri, Joseph Landolfi, Rani Sebti, Gregory Sugalski, Jason Korcak, Urszula Bednarz, Daniel W. Varga, Cristina Cicogna, Shivam Mathura, Bindu Balani, Scott M. Berry, Michael Marafelias, Laurie G Jacobs, Ronaldo C. Go, Julia A. Piwoz
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237693 (2020)
PLOS ONE, 15(8):e0237693
BASE-Bielefeld Academic Search Engine
PLoS ONE
PLOS ONE, 15(8):e0237693
BASE-Bielefeld Academic Search Engine
PLoS ONE
BackgroundHydroxychloroquine has been touted as a COVID-19 treatment. Tocilizumab, an inhibitor of IL-6, has been proposed as a treatment of critically ill patients.ObjectiveTo describe the association between mortality and hydroxychloroquine or toci
Autor:
Juan C. Paramo, Sajeve S. Thomas, William Schmidt, Pallavi Kumar, Eddy C. Hsueh, Deepti Behl, Vinay Kumar Gupta, Prejesh Philips, Edward C. McCarron, Arvinda Padmanabhan, Adam C. Berger, Daniel Milton, Tawnya L. Bowles, Robert Weber, Jeffrey B Travers, Brendan D. Curti, Suthee Rapisuwon, Robert H.I. Andtbacka, Peter D. Beitsch, Mohammed M. Milhem, Edward A. Levine, John R. Hyngstrom, Suprith Badarinath, Anna Bar, John Keech, Marcus O. Butler, Omid Hamid, Brian R. Gastman, Andrew L. Pecora, Craig L. Slingluff, Takami Sato, J. Thaddeus Beck, Sekwon Jang, Catalin Mihalcioiu, John A. Glaspy, Karl D. Lewis, Shernan G. Holtan, Joël Claveau, Montaser Shaheen, Leonel Hernandez-Aya, Jose Lutzky, Brent A. Blumenstein, Joanna J Peterkin, Svetomir N. Markovic, Sujith Kalmadi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundMost patients with advanced melanomas relapse after checkpoint blockade therapy. Thus, immunotherapies are needed that can be applied safely early, in the adjuvant setting. Seviprotimut-L is a vaccine containing human melanoma antigens, plu
Autor:
Andrew L. Pecora, Michele L. Donato, Ling Cai, Melissa Baker, Daniel Kim, Scott D. Rowley, David H. Vesole, Barbara Adler-Brecher, Hongkun Wang, Alan P Skarbnik
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:2047-2055
Most patients eligible for allogeneic hematopoietic stem cell transplantation will require identification of an alternate (unrelated or mismatched related) donor. We explored the transplantation outcomes for a sequential series of 54 patients undergo
Autor:
Kevin, Kalinsky, Sandra, Lee, Krista M, Rubin, Donald P, Lawrence, Anthony J, Iafrarte, Darell R, Borger, Kim A, Margolin, Mario M, Leitao, Ahmad A, Tarhini, Henry B, Koon, Andrew L, Pecora, Anthony J, Jaslowski, Gary I, Cohen, Timothy M, Kuzel, Christopher D, Lao, John M, Kirkwood
Publikováno v:
Cancer. 123(14)
KIT-directed tyrosine kinase inhibitors such as imatinib have demonstrated benefits in KIT-mutant (KIT+) mucosal, acral, vulvovaginal, and chronically sun-damaged (CSD) melanoma. Dasatinib has superior preclinical activity in comparison with other ty
Autor:
Stuart L. Goldberg, Michele L. Donato, Andrew L. Pecora, Phyllis McKiernan, Themba Nyirenda, David H. Vesole, Melissa Baker, Scott D. Rowley, David S. Siegel, Anthony R. Mato, Andre Goy
Publikováno v:
Biology of Blood and Marrow Transplantation. 20:1211-1216
We conducted a study of patients with multiple myeloma (MM) undergoing allogeneic transplantation to evaluate outcome parameters. Fifty-seven consecutive patients with MM received an allogeneic transplantation between 2004 and 2011 at our institution
Autor:
Luciano Castiello, Ronald E. Gress, Robert Korngold, Susan F. Leitman, Dennis D. Hickstein, Bruce L. Levine, Andre Goy, Frances T. Hakim, Michele L. Donato, Nancy M. Hardy, David F. Stroncek, Seth M. Steinberg, David Halverson, Hahn Khuu, Juan Gea-Banacloche, Miriam E. Mossoba, Claude Sportes, Scott D. Rowley, Carl H. June, Steven Z. Pavletic, Marianna Sabatino, Andrew L. Pecora, Jacopo Mariotti, Michael R. Bishop, Daniel H. Fowler
Publikováno v:
Blood. 121:2864-2874
In experimental models, ex vivo induced T-cell rapamycin resistance occurred independent of T helper 1 (Th1)/T helper 2 (Th2) differentiation and yielded allogeneic CD4+ T cells of increased in vivo efficacy that facilitated engraftment and permitted
Autor:
Richard R. Furman, Michael L. Grossbard, Jeffrey L. Johnson, Andrew L. Pecora, Peter A. Cassileth, Sin-Ho Jung, Bruce A. Peterson, Lee M. Nadler, Arnold Freedman, Ruthee-Lu Bayer, Nancy L. Bartlett, David D. Hurd, Bruce D. Cheson, null For The Cancer Leukemia Group B And
Publikováno v:
Leukemia & Lymphoma. 52:587-596
Anti-B4-blocked ricin (anti-B4-bR) is a potent immunotoxin directed against the CD 19 antigen. Previous phase I and II studies suggested a possible role for anti-B4-bR as consolidation after high-dose chemotherapy and autologous stem cell transplant.
Autor:
Jeanette Carreras, Brian J. Bolwell, Philip A. Rowlings, Thomas C. Shea, Julie M. Vose, Yi Bin Chen, David I. Marks, Timothy S. Fenske, Osman Ilhan, Jane N. Winter, Rammurti T. Kamble, Andrew L. Pecora, Peter H. Wiernik, Koen van Besien, John Lister, Hillard M. Lazarus, Parameswaran Hari, Richard E. Champlin, Cesar O. Freytes, Mei-Jie Zhang, Robert Peter Gale, Reinhold Munker, Gregory A. Hale, Patrick J. Stiff, J. Douglas Rizzo, Dipnarine Maharaj, H. Jean Khoury, Mitchell S. Cairo
Publikováno v:
Biology of Blood and Marrow Transplantation. 15(11):1455-1464
Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens for diffuse large B-cell lymphoma (DLBCL) has resulted in improved survival. Despite this progress, many patients develop refractory or recurrent DLBCL and then rec